Melanoma
Latest News
Study spotlights clinicopathologic features, survival outcomes of pediatric melanoma
The median Breslow thickness was 2.7 mm in children and 1.0 mm in adolescents.
Food for Thought
The Role of Dietary Antioxidants in Melanoma and Nonmelanoma Skin Cancer
We review the effects of frequently encountered antioxidants and vitamins suggested for the chemoprevention of melanoma and nonmelanoma skin...
Latest News
Adverse events linked to better survival with ICIs in melanoma
“We feel these findings will help clinicians in discussions with patients and in clinical decision-making after adverse events develop,” one of...
Latest News
Melanoma mortality rates fell in 2010s as new therapies took hold
Immunotherapy and targeted therapy appear to be paying dividends, new study finds.
Latest News
Subset of patients with melanoma have very low mortality risk
The authors were interested in identifying lesions that are currently diagnosed as melanoma but might lack the capacity for metastasis.
Latest News
Study eyes sunscreens marketed to individuals with skin of color
The average number of allergens per product was 4.7, most commonly fragrance/botanicals, tocopherol, sodium benzoates/derivatives, and sorbitan...
Latest News
What are the risk factors for Mohs surgery–related anxiety?
“Routinely recommending consultations may not be the best approach for improving anxiety outcomes,” the study authors wrote.
Latest News
Who’s more likely to develop a second primary melanoma?
"High numbers of nevi and high genetic predisposition were more strongly associated with second [rather] than first primary melanomas."
Conference Coverage
Latinx and melanoma: Barriers and opportunities
A qualitative study in California reveals challenges and attitudes that could be addressed with new melanoma outreach and prevention strategies....
Conference Coverage
Stage 3 melanoma attacked with immunotherapy and a virus-like particle
Phase 2 trial achieves some success, and responders had infiltrate of plasmacytoid dendritic cells.
Conference Coverage
Stool transplants may boost immunotherapy success in melanoma
A phase 1 trial shows good clinical response after transplants from healthy donors.